TMDX TransMedics Group, Inc. Common Stock ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Best Electromedical Stocks 2026 →

TransMedics Group (TMDX) Stock: Buy, Sell, or Hold?

$92.01
+1.07 (+1.17%) β–²
5d: +26.47% 30d: +16.27% 90d: +2.64%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (20%)
Quality Score
41/100
Position
EXTENDED
30-Day Fair Range
$68.17 – $82.67
Position: EXTENDED
Forward P/E & Valuation
37.0x FAIR
vs 33.5x historical avg
Wall Street Target
$104.55
+13.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$64.64 / $97.56
Trend: Sideways
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: TMDX is 11.3% above its trading range ($82.67). Market expects 3.4% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Nov 6, 2026 at $87.32 · last confirmed Nov 9, 2026

Strength: 7.7/10

Get Alerted When TMDX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$121.02
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$75.14
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: TMDX is currently trading at $92.01, which is considered extended relative to its 30-day fair value range of $68.17 to $82.67. From a valuation perspective, the stock is trading at a premium (Forward PE: 37.0) compared to its historical average (33.5). At these levels, the market is pricing in 3.4% annual earnings growth.

Technical Outlook: Technically, TMDX is showing sideways momentum. Immediate support is located at $64.64, while resistance sits at $97.56.

Market Sentiment: TMDX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $104.55 (+13.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $68.17 - $82.67
Company Quality Score 41/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 20.0%

Trading Range & Key Levels

30-Day Trading Range $68.17 - $82.67
Current vs Trading Range EXTENDED
Support Level $64.64
Resistance Level $97.56
Current Trend Sideways
Technical data as of Nov 11, 2026

Protect Your Profits

Holding TMDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price significantly overextended (+11.3% above its trading range)
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($104.55)
  • BULLISH: Expecting earnings turnaround to 3.4% growth with 41.1% revenue growth
  • WARNING: Composite score 41/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 37.01
Wall Street Target $104.55 (+13.6%)
Revenue Growth (YoY) 41.1%
Earnings Growth (YoY) -29.8%
Profit Margin 19.9%
Valuation Premium vs History +3.4% premium
PE vs Historical 37.0 vs 33.5 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.4% (market-implied from PE analysis)
1-Year Target $95.14 (+3%)
2-Year Target $98.37 (+7%)
3-Year Target $101.72 (+11%)
3-Yr Target (if PE normalizes) (PE: 37β†’34) PE COMPRESSION $92.06 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 37.0, Growth: 48.9%) $304.05 (+231%)
Base: (SPY PE: 19.9, Growth: 48.9%) $163.14 (+77%)
Bear: (PE: 16.9, Growth: 48.9%) $138.67 (+51%)
πŸ“ˆ Valuation based on Current Earnings
Trailing PE: 25.56 | Current EPS (TTM): $3.67
Bull Case $69.88 (-23%)
Analyst growth -32.3%, PE expands to 28.1
Base Case $63.53 (-30%)
Market implied -32.3%, PE stable at 25.6
Bear Case $63.78 (-30%)
Severe decline -20.0%, PE contracts to 21.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share TMDX Analysis

Share this live TMDX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (TMDX)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment on $TMDX intensifies on StockTwits with no new news articles available.
Key Retail Themes: Bullish sentiment Absence of new news
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 4:27 PM ET
Data refreshes hourly during market hours. Next update: 5:27 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for TMDX.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$98 52 HOLD
BSX
Boston Scientific Corp
BUY
31 analysts
$50 53 HOLD
SYK
Stryker Corporation
STRONG BUY
30 analysts
$340 38 SELL
EW
Edwards Lifesciences Corp
STRONG BUY
30 analysts
$112 31 SELL
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$119 38 SELL

Advanced TMDX Option Strategies

Professional options setups generated by AI based on today's TMDX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive TMDX Research Pages
TMDX Technical Chart TMDX Price Prediction TMDX Intrinsic Value DCF TMDX Earnings Date Why is TMDX Moving Today? TMDX Investment Advisor TMDX Fair Price Analyzer TMDX Options Chain TMDX Options Advisor TMDX Options Analysis TMDX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals